Malignant melanoma

Malignant melanoma is an aggressive malignancy arising from the transformation of melanocytes, the melanin-producing cells derived from the neural crest Although it most frequently develops in the integumentary system—primarily affecting cutaneous sites in fair-skinned adults with exposure to ultraviolet radiation—it can also originate in extracutaneous tissues such as mucosal surfaces, ocular structures, and the leptomeninges

Malignant melanoma is an aggressive malignancy arising from the transformation of melanocytes, the melanin-producing cells derived from the neural crest

Although it most frequently develops in the integumentary system—primarily affecting cutaneous sites in fair-skinned adults with exposure to ultraviolet radiation—it can also originate in extracutaneous tissues such as mucosal surfaces, ocular structures, and the leptomeninges

Although it most frequently develops in the integumentary system—primarily affecting cutaneous sites in fair-skinned adults with exposure to ultraviolet radiation—it can also originate in extracutaneous tissues such as mucosal surfaces, ocular structures, and the leptomeninges

Clinically, cutaneous lesions often present as pigmented macules, papules, or plaques characterized by asymmetry, irregular borders, variegated coloration, and changes in size or elevation Pathophysiologically, malignant melanoma is driven by acquired genetic alterations—such as mutations in the MAPK pathway—and possesses an early horizontal and subsequent vertical growth phase marked by significant local tissue invasion and high propensity for early lymphatic and hematogenous metastasis

Clinically, cutaneous lesions often present as pigmented macules, papules, or plaques characterized by asymmetry, irregular borders, variegated coloration, and changes in size or elevation

Pathophysiologically, malignant melanoma is driven by acquired genetic alterations—such as mutations in the MAPK pathway—and possesses an early horizontal and subsequent vertical growth phase marked by significant local tissue invasion and high propensity for early lymphatic and hematogenous metastasis

Pathophysiologically, malignant melanoma is driven by acquired genetic alterations—such as mutations in the MAPK pathway—and possesses an early horizontal and subsequent vertical growth phase marked by significant local tissue invasion and high propensity for early lymphatic and hematogenous metastasis

Pathophysiologically, malignant melanoma is driven by acquired genetic alterations—such as mutations in the MAPK pathway—and possesses an early horizontal and subsequent vertical growth phase marked by significant local tissue invasion and high propensity for early lymphatic and hematogenous metastasis